A few days ago, the joint spirit had already been approved by several countries.

And because Li Changhua has already prepared all the work, now that the approval is over, he can prepare for the official sale and begin to accept the test of patients.

Although the joint spirit is not sold at the same time in the world, the population of the selected country can be ranked high, so the sales of the joint spirit will not be low.

For the drug of joint spirit, Changhua Pharmaceutical has not done much publicity for this in China.

It's just that a few days ago, Li Changhua held a new drug conference to announce the clinical trial of the joint Lingtong guò in human beings, and it was approved by the Food and Drug Administration.

In addition, Changhua Pharmaceutical has not done other publicity for the joint spirit, let alone invited celebrities to shoot advertisements.

However, because the drugs continuously launched by Changhua Pharmaceutical before were all heavyweight drugs, they had a huge impact on the drug market and changed the original situation.

Therefore, the influence and popularity of Changhua Pharmaceutical are not low, and the media across the country are paying attention to Changhua Pharmaceutical at any time.

Now that Changhua Pharmaceutical is going to launch a new drug, these media will take the initiative to report on it, which is much better than the effect of advertising.

Of course, this is not completely without harm, as long as Changhua Pharmaceutical has any negative news, or if there is any problem with the joint spirit, then these media will also report it mercilessly.

Because these media are just attractive news, and Changhua Pharmaceutical itself is big news, and there are many patients now. Or their families are very concerned about Changhua Pharmaceutical. It is hoped that Changhua Pharmaceutical can launch more useful drugs.

It is because there are so many people looking forward to and paying attention. Therefore, the media across the country will be the first to report the news of Changhua Pharmaceutical.

Therefore, as long as Changhua Pharmaceutical does not have any errands, or any negative news, then these reports are the best publicity and advertising, and Changhua Pharmaceutical does not need to spend a penny.

Therefore, there should be no problem with the sales of joint spirit in China.

In foreign sales, there are agents doing publicity, so naturally there is no need to worry about Changhua Pharmaceutical. In order to obtain greater benefits for themselves, the agent will naturally deal with these things.

Therefore, today's sales of joint spirit will definitely not be bad.

Li Changhua took out a report, put it in front of Su Zhe, and said: "This is the latest output plan, which has been implemented since two days ago. ”

Su Zhe didn't say anything, he picked up the production report and looked at it.

Prior to this, the daily production of drugs such as thawing was maintained at 11 million tablets. Of these, 5 million pieces were supplied to the Liu Group for sale in the domestic market. The other 6 million tablets were provided to foreign distributors for sale.

However, now because of the addition of several new cooperative agents, the output of the drug will naturally increase.

So now the production of each drug has increased, and it has directly doubled, and now in addition to the defrost, the daily output of several other drugs is 22 million tablets, including the joint spirit that has just been launched today.

Although the joint spirit has just been launched, the sales volume should not be so high, but the market demand for the joint spirit is very large, and the sales volume will soon increase to the same as the blue elixir and other drugs.

Therefore, the current output of Joint Spirit, just like drugs such as Blue Elixir, is 22 million tablets per day.

However, the daily output of thawing spirit has not increased so much, because ALS is a very rare disease, so the market demand is limited, so the domestic production has been reduced to four million tablets, and the total daily output is 18 million tablets, which is 4 million tablets less than other drugs.

If you don't continue to develop foreign markets, maybe the sales of thawing spirit still need to be controlled.

Of course, this is a situation that will not arise much later, so there is no need to think too much about it now.

Of each drug, except for 5 million tablets, which were left for domestic use, the rest of the drugs were supplied to distributors in other countries.

Because with the direct doubling of the production of medicines, the amount of healing potions consumed each month will also increase rapidly.

According to the current production plan, Changhua Pharmaceutical needs at least 310 barrels of therapeutic potions consumed every month, and all of them are high-concentration therapeutic potions.

But fortunately, Su Zhe is now providing more and more healing potions, so he can still meet the consumption.

Today alone, he's sent seven hundred barrels of healing potions, which can meet at least two months' production needs, so there's no need to worry at all.

Therefore, Su Zhe did not have any opinion on Li Changhua's new output plan, and directly agreed.

As for the pricing of the joint spirit, it was resolved at an earlier meeting.

The cost of producing a single piece of Joint Spirit is four pieces, which includes the cost of healing potions and other raw materials, as well as various costs such as taxes, and labor costs.

In addition, because the joint spirit and the blue elixir are the same, an additional yuan needs to be paid to Su Zhe for each piece sold, which is compensation for the formula he came up with, and this yuan is also included in the cost.

The ex-factory price of the joint spirit is five yuan, and the net profit brought by each piece of joint spirit to Changhua Pharmaceutical is one yuan, and the final retail price is six yuan.

However, this is the domestic price, and the foreign price is not the same.

The ex-factory price of drugs provided to foreign agents will be increased by 50%, that is, seven yuan five, and every piece of joint spirit sold can bring three yuan and five net profits to Changhua Pharmaceutical.

As for the retail price abroad, it is up to the agent to set it.

Of course, the profit of the foreign retail price cannot exceed 20%, which is also indicated in the agency agreement, and the agents have also agreed.

Therefore, no matter how high the retail price abroad is, it will not be much higher, and it will still be within a reasonable range.

Su Zhe is not worried about this, after all, there is an agreement first, and he is not worried that foreign agents will mess around and make crazy money.

After Li Changhua finished talking about the medicine, he talked about the payment for the treatment potion: "From the 15th of last month to yesterday, the factory has consumed a total of 90 barrels of treatment potion, worth 3.6 billion yuan, and this payment will be transferred to your account in a few days." ”

This is what Su Zhe and Li Changhua had agreed before, Changhua Pharmaceutical will pay as much as it uses every month.

As for the remaining healing potions, they will be used as a reserve for Changhua Pharmaceutical and will be used later.

Therefore, after Su Zhe heard this, he just nodded and didn't say anything. (To be continued......)